← Open Payments lookup

DILIPKUMAR JOSHI: Open Payments

NPI 1669565537 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,146 in 61 payments from 14 companies in 2025. Trend: 2023 $731 · 2024 $1,050 · 2025 $1,146

Food & beverage: $1,146
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.8$173
Otsuka America Pharmaceutical, Inc.10$167
Alkermes, Inc.7$147
Vanda Pharmaceuticals Inc.8$130
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$120
Lundbeck LLC6$117
ABBVIE INC.4$72
Supernus Pharmaceuticals, Inc.4$70
Takeda Pharmaceuticals U.S.A., Inc.2$35
Braeburn Inc.2$31

Products named: COBENFY, REXULTI, LYBALVI, ABILIFY ASIMTUFII, CAPLYTA, VRAYLAR, FANAPT, Qelbree.

Industry payments across DE — which companies pay providers there.